Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic immune-inflammation index as predictors of venous thromboembolism in patients with diffuse large B-cell lymphoma
Waad Almalki, Atheer Alenezi, Rawan Almutairi, Anfal Alsadhan · 2026
Read Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic immune-inflammation index as predictors of venous thromboembolism in patients with diffuse large B-cell lymphoma by Waad Almalki, Atheer Alenezi, Rawan Almutairi, Anfal Alsadhan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13419304.txt.
Description
Waad Almalki and co-workers tested cheap blood-count ratios in 2026 as clot flags for diffuse large B-cell lymphoma. Clots threaten lymphoma patients, yet whether neutrophil, platelet, and inflammation ratios flag risk in this cancer was largely untested, so the team studied 224 patients before chemotherapy.
Thirty-one patients developed venous clots, and all three ratios ran higher in that group, with neutrophil and platelet ratios standing as independent flags after adjustment. Clinicians gain simple lab cutoffs for spotting lymphoma patients who may need closer clot watch and for hematologists weighing clot drugs.
Catalog record
| CREATOR | Waad Almalki, Atheer Alenezi, Rawan Almutairi, Anfal Alsadhan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |